View Author
virus vaccine response infection animal syncytial infant syncytial virus study protein vaccination group epitope challenge disease antibody figure syncytial virus infection 0/4 influenza t cells fluenza expression hrsv-specific peptide antigen chapter class cytokine result table pandemic virol control number assay tract adjuvanted autologou t-cell hrsv infection patient score bbg 2na elispot assay level culture protection titer bronchiolitis alveolar model autologous blcl 1 dpi ph 1n elispot immunol convalescent phase tissue macaque netherland il -13 influenza virus infections weight 4 dpi phase indo-a -13 0.5 antigen expression cytotoxic stimulation hla-dp osterhau virus antigen expression immunity rmva-f vaccinia treatment rsv-speci
10 Most Recent Publications
|
Consecutive CT in vivo lung imaging as quantitative parameter of influenza vaccine efficacy in the ferret model
(Article)
Veldhuis Kroeze, E.J.B. Stittelaar, K.J. Teeuwsen, V.J.P. Dijkshoorn, M.L. Amerongen, G. van Waal, L. de Kuiken, T. Krestin, G.P. Hinkula, J. Osterhaus, A.D.M.E. |
2012-12-07
|
|
Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets
(Article)
Brand, J.M.A. van den Stittelaar, K.J. Amerongen, G. van Reperant, L.A. Waal, L. de Osterhaus, A.D.M.E. Kuiken, T. |
2012-08-08
|
|
Pulmonary pathology of pandemic influenza A/H1N1 virus (2009)-infected ferrets upon longitudinal evaluation by computed tomography
(Article)
Kroeze, E.J.B.V. Amerongen, G. van Dijkshoorn, M.L. Simon, J.H. Waal, L. de Hartmann, I.J.C. Krestin, G.P. Kuiken, T. Osterhaus, A.D.M.E. Stittelaar, K.J. |
2011-08-01
|
|
Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets
(Article)
Baras, B. Waal, L. de Mossman, S.P. Osterhaus, A.D.M.E. Stittelaar, K.J. Jacob, V. Giannini, S. Veldhuis Kroeze, E.J.B. Brand, J.M.A. van den Amerongen, G. van Simon, J.H. Hanon, E. |
2011-02-02
|
|
Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets
(Article)
Baras, B. Stittelaar, K.J. Hanon, E. Mossman, S.P. Kuiken, T. Jacob, V. Bernhard, R. Giannini, S. Waal, L. de Amerongen, G. van Simon, J.H. Osterhaus, A.D.M.E. |
2011-02-01
|
|
Identification of helper T cell master regulator candidates using the polar score method
(Article)
Ham, H.J. van den Waal, L. de Andeweg, A.C. Boer, R.J. de |
2010-09-01
|
|
T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cells
(Article)
Waal, L. de Süzer, Y. Wyatt, L.S. Sintnicolaas, K. Sutter, G. Moss, B. Osterhaus, A.D.M.E. Swart, R.L. de |
2006-12-01
|
|
Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology
(Article)
Wyatt, L.S. Yüksel, S. Moss, B. Niesters, H.G.M. Osterhaus, A.D.M.E. Amerongen, G. van Waal, L. de |
2004-02-25
|
|
Identification of a common HLA-DP4-restricted T-cell epitope in the conserved region of the respiratory syncytial virus G protein
(Article)
Waal, L. de Yüksel, S. Brandenburg, A.H. Langedijk, J.P. Sintnicolaas, K. Swart, R.L. de Osterhaus, A.D.M.E. Verjans, G.M.G.M. |
2004-01-01
|
|
Respiratory Syncytial Virus; Anti-viral immunity in humans and macaques.
(Doctoral Thesis)
Waal, L. de |
2003-12-10
|
